Business · Markets · 11 hrs ago
Swiss stocks rise as investors look ahead to quarterly earnings
Swiss stocks started the week higher on Monday, with the main SMI index gaining ground.
The rise followed positive signals from US markets and a slight easing in bond markets.
Roche and Novartis were among the large companies supporting the market, while Roche had released new data on an experimental treatment for swelling in the centre of the retina.
Smaller shares moved sharply: EvoNext rose after agreeing to merge with sports technology company Ascend Sport Technology, while Centiel fell after warning that its profit would be lower than expected.
Idorsia shares also rose after it released new data on its blood-pressure drug Aprocitentan.
Investors are now looking to the start of the third-quarter earnings season, with results from Swiss companies including Givaudan, Lonza and VAT, and major US banks, due to draw attention in the coming days.
Swiss stocks rose on Monday, supported by positive signals from the United States and easing pressure in bond markets.
The SMI gained 0.6% to 13,863 points, while the SMIM rose 0.3% and the SPI advanced 0.5%.
Investors are looking ahead to the start of third-quarter earnings reporting in the coming days.
Givaudan, Lonza and VAT are among the Swiss companies expected to draw attention, while major US banks are also due to report.
Roche and Novartis helped support the market, while Centiel shares fell after the company issued a profit warning.
- Who
- Swiss stocks and investors tracking the market.
- What
- Swiss stock indexes rose as investors looked ahead to third-quarter earnings reports.
- When
- Monday, October 12, 2026.
- Where
- Switzerland.
- Why
- Positive signals from the United States and a slight easing in bond markets supported the market; investors are also anticipating earnings reports.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- SMI
- Up 0.6% to 13,863 points
- SMIM
- Up 0.3% to 3,074 points
- SPI
- Up 0.5% to 19,631 points
- Earnings focus
- Third-quarter reporting starts in the coming days
- Swiss companies in focus
- Givaudan, Lonza and VAT




